Value Bridge — FLAGSTAFF MEDICAL CENTER
Current $-4M → Target $7M (+$10.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.0M
Current EBITDA
$6.6M
Target EBITDA
+$10.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.4M
Payer Mix Optimization
$5.7M
Cost to Collect Reduction
$1.9M
Clean Claim Improvement
$1.4M
Volume & Rate Growth
$9.6M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-4M to $7M. The highest-impact lever is Volume & Rate Growth at $3.8M probability-weighted.
IC talking point: "We see $11M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $116M in equity value creation."